• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

假激酶Trib1调节耗竭性T细胞向KLR CD8效应状态的转变,其缺失可改善检查点阻断效果。

The pseudokinase Trib1 regulates the transition of exhausted T cells to a KLR CD8 effector state and its deletion improves checkpoint blockade.

作者信息

McClory Susan E, Bardhan Oishi, Rome Kelly S, Giles Josephine R, Baxter Amy E, Xu Lanwei, Gimotty Phyllis A, Faryabi Robert B, Wherry E John, Pear Warren S, Jordan Martha S

机构信息

Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Department of Pathology and Laboratory Medicine, Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

出版信息

bioRxiv. 2023 Feb 16:2023.02.16.528833. doi: 10.1101/2023.02.16.528833.

DOI:10.1101/2023.02.16.528833
PMID:36824931
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9948998/
Abstract

T cell exhaustion (T ) impairs the ability of T cells to clear chronic infection or cancer. While exhausted T cells are hypofunctional, some exhausted T cells retain effector gene signatures, a feature that is associated with expression of KLRs (killer lectin-like receptors). Although KLR T cells may improve control of chronic antigen, the signaling molecules regulating this population are poorly understood. Using scRNA-seq, flow cytometry, RNA velocity, and scTCR-seq, we demonstrate that deleting the pseudokinase Trib1 shifts T towards CX3CR1 intermediates (T ) with robust enrichment of KLR CD8 T cells (T ) via clonal T cell expansion. These changes are associated with globally increased KLR gene expression throughout the exhaustion program. Further, Trib1 loss augments anti-PD-L1 blockade to improve viral clearance by expanding the T population. Together, these data identify Trib1 as an important regulator of T cell exhaustion whose targeting enhances the KLR effector state and improves the response to checkpoint inhibitor therapy.

摘要

T细胞耗竭(T )会损害T细胞清除慢性感染或癌症的能力。虽然耗竭的T细胞功能低下,但一些耗竭的T细胞保留了效应基因特征,这一特征与杀伤凝集素样受体(KLRs)的表达相关。尽管KLR T细胞可能会改善对慢性抗原的控制,但调节这一细胞群体的信号分子仍知之甚少。通过单细胞RNA测序(scRNA-seq)、流式细胞术、RNA速度分析和单细胞T细胞受体测序(scTCR-seq),我们证明,删除假激酶Trib1会使T 向CX3CR1 中间细胞(T )转变,通过克隆性T细胞扩增使KLR CD8 T细胞(T )大量富集。这些变化与整个耗竭过程中KLR基因的整体表达增加有关。此外,Trib1缺失通过扩大T 群体增强了抗程序性死亡配体1(PD-L1)阻断作用,从而改善病毒清除。总之,这些数据表明Trib1是T细胞耗竭的重要调节因子,靶向Trib1可增强KLR 效应状态并改善对检查点抑制剂疗法的反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/deed/9948998/401992c3428d/nihpp-2023.02.16.528833v1-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/deed/9948998/63bee0f116cf/nihpp-2023.02.16.528833v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/deed/9948998/e6e30772c150/nihpp-2023.02.16.528833v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/deed/9948998/922cd86e6b2f/nihpp-2023.02.16.528833v1-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/deed/9948998/af04624aa59d/nihpp-2023.02.16.528833v1-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/deed/9948998/401992c3428d/nihpp-2023.02.16.528833v1-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/deed/9948998/63bee0f116cf/nihpp-2023.02.16.528833v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/deed/9948998/e6e30772c150/nihpp-2023.02.16.528833v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/deed/9948998/922cd86e6b2f/nihpp-2023.02.16.528833v1-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/deed/9948998/af04624aa59d/nihpp-2023.02.16.528833v1-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/deed/9948998/401992c3428d/nihpp-2023.02.16.528833v1-f0005.jpg

相似文献

1
The pseudokinase Trib1 regulates the transition of exhausted T cells to a KLR CD8 effector state and its deletion improves checkpoint blockade.假激酶Trib1调节耗竭性T细胞向KLR CD8效应状态的转变,其缺失可改善检查点阻断效果。
bioRxiv. 2023 Feb 16:2023.02.16.528833. doi: 10.1101/2023.02.16.528833.
2
The pseudokinase Trib1 regulates the transition of exhausted T cells to a KLR CD8 effector state, and its deletion improves checkpoint blockade.伪激酶 Trib1 调控耗竭性 T 细胞向 KLRG1+CD8+效应状态的转变,其缺失可改善检查点阻断。
Cell Rep. 2023 Aug 29;42(8):112905. doi: 10.1016/j.celrep.2023.112905. Epub 2023 Jul 31.
3
Trib1 regulates T cell differentiation during chronic infection by restraining the effector program.TRIB1 通过抑制效应器程序调节慢性感染期间 T 细胞的分化。
J Exp Med. 2020 May 4;217(5). doi: 10.1084/jem.20190888.
4
PD-L1 Checkpoint Inhibition Narrows the Antigen-Specific T Cell Receptor Repertoire in Chronic Lymphocytic Choriomeningitis Virus Infection.PD-L1 检查点抑制缩小了慢性淋巴细胞脉络丛脑膜炎病毒感染中抗原特异性 T 细胞受体库。
J Virol. 2020 Aug 31;94(18). doi: 10.1128/JVI.00795-20.
5
A Combination of Anti-PD-L1 Treatment and Therapeutic Vaccination Facilitates Improved Retroviral Clearance via Reactivation of Highly Exhausted T Cells.抗 PD-L1 治疗联合治疗性疫苗通过激活高度耗竭的 T 细胞促进逆转录病毒清除。
mBio. 2021 Feb 2;12(1):e02121-20. doi: 10.1128/mBio.02121-20.
6
Divergent clonal differentiation trajectories of T cell exhaustion.T 细胞耗竭的不同克隆分化轨迹。
Nat Immunol. 2022 Nov;23(11):1614-1627. doi: 10.1038/s41590-022-01337-5. Epub 2022 Oct 26.
7
Functional Exhaustion of HBV-Specific CD8 T Cells Impedes PD-L1 Blockade Efficacy in Chronic HBV Infection.HBV 特异性 CD8 T 细胞功能耗竭阻碍慢性 HBV 感染中 PD-L1 阻断的疗效。
Front Immunol. 2021 Sep 13;12:648420. doi: 10.3389/fimmu.2021.648420. eCollection 2021.
8
PD-1/CTLA-4 Blockade Leads to Expansion of CD8PD-1 TILs and Results in Tumor Remission in Experimental Liver Cancer.程序性死亡受体1/细胞毒性T淋巴细胞相关蛋白4阻断疗法可导致CD8程序性死亡受体1肿瘤浸润淋巴细胞扩增,并使实验性肝癌出现肿瘤缓解。
Liver Cancer. 2022 Oct 7;12(2):129-144. doi: 10.1159/000526899. eCollection 2023 Jun.
9
Impact of CD4 T cells on intratumoral CD8 T-cell exhaustion and responsiveness to PD-1 blockade therapy in mouse brain tumors.CD4 T 细胞对脑肿瘤内 CD8 T 细胞耗竭和对 PD-1 阻断治疗反应性的影响。
J Immunother Cancer. 2022 Dec;10(12). doi: 10.1136/jitc-2022-005293.
10
Expansion of tumor-reactive CD8 T cell clonotypes occurs in the spleen in response to immune checkpoint blockade.肿瘤反应性 CD8 T 细胞克隆型的扩增发生在脾脏中,以响应免疫检查点阻断。
Sci Immunol. 2024 Sep 13;9(99):eadi3487. doi: 10.1126/sciimmunol.adi3487.

本文引用的文献

1
Clonal lineage tracing reveals mechanisms skewing CD8+ T cell fate decisions in chronic infection.克隆谱系追踪揭示了慢性感染中 CD8+ T 细胞命运决定偏向的机制。
J Exp Med. 2023 Jan 2;220(1). doi: 10.1084/jem.20220679. Epub 2022 Oct 31.
2
Divergent clonal differentiation trajectories of T cell exhaustion.T 细胞耗竭的不同克隆分化轨迹。
Nat Immunol. 2022 Nov;23(11):1614-1627. doi: 10.1038/s41590-022-01337-5. Epub 2022 Oct 26.
3
Shared and distinct biological circuits in effector, memory and exhausted CD8 T cells revealed by temporal single-cell transcriptomics and epigenetics.
通过时空调控单细胞转录组学和表观遗传学揭示效应器、记忆和耗竭 CD8 T 细胞中的共享和独特的生物学回路。
Nat Immunol. 2022 Nov;23(11):1600-1613. doi: 10.1038/s41590-022-01338-4. Epub 2022 Oct 21.
4
Programme of self-reactive innate-like T cell-mediated cancer immunity.自我反应性先天样 T 细胞介导的癌症免疫计划。
Nature. 2022 May;605(7908):139-145. doi: 10.1038/s41586-022-04632-1. Epub 2022 Apr 20.
5
Human epigenetic and transcriptional T cell differentiation atlas for identifying functional T cell-specific enhancers.人类表观遗传学和转录 T 细胞分化图谱,用于鉴定功能 T 细胞特异性增强子。
Immunity. 2022 Mar 8;55(3):557-574.e7. doi: 10.1016/j.immuni.2022.02.004.
6
KIRCD8 T cells suppress pathogenic T cells and are active in autoimmune diseases and COVID-19.KIRCD8 T 细胞抑制致病性 T 细胞,并在自身免疫性疾病和 COVID-19 中活跃。
Science. 2022 Apr 15;376(6590):eabi9591. doi: 10.1126/science.abi9591.
7
The Pseudokinase TRIB1 in Immune Cells and Associated Disorders.免疫细胞中的假激酶TRIB1及其相关疾病
Cancers (Basel). 2022 Feb 17;14(4):1011. doi: 10.3390/cancers14041011.
8
CellRank for directed single-cell fate mapping.细胞排序用于有向单细胞命运图谱绘制。
Nat Methods. 2022 Feb;19(2):159-170. doi: 10.1038/s41592-021-01346-6. Epub 2022 Jan 13.
9
BATF regulates progenitor to cytolytic effector CD8 T cell transition during chronic viral infection.BATF 调控慢性病毒感染期间祖细胞向细胞毒效应 CD8 T 细胞的转变。
Nat Immunol. 2021 Aug;22(8):996-1007. doi: 10.1038/s41590-021-00965-7. Epub 2021 Jul 19.
10
The architectural design of CD8+ T cell responses in acute and chronic infection: Parallel structures with divergent fates.急性和慢性感染中 CD8+ T 细胞反应的建筑设计:具有不同命运的平行结构。
J Exp Med. 2021 Apr 5;218(4). doi: 10.1084/jem.20201730.